Literature DB >> 18410659

Efficacy of laparoscopic subtotal hysterectomy in the management of menorrhagia: 400 consecutive cases.

J Erian1, M Hassan, A Pachydakis, S Chandakas, I Wissa, N Hill.   

Abstract

STUDY
OBJECTIVE: To assess the safety and patient satisfaction of laparoscopic subtotal hysterectomy (LSH) using a standardised surgical technique.
DESIGN: Prospective observational study.
SETTING: Princess Royal University Hospital, Chelsfield Park Hospital and Sloane Hospital, Kent, UK. PATIENTS AND MATERIALS: Four hundred consecutive women with menorrhagia underwent LSH. The procedure was performed using the Plasma Kinetic Bipolar Diathermy (Gyrus International Ltd, Berkshire, UK) for pedicle ligation and the Lap Loop system (Roberts Surgical Healthcare Ltd, Kidderminster, UK) to detach the cervix. An electromechanical morcellator (Morcellex; Ethicon Women's Health and Urology, Cincinnati, OH, USA) was used to remove the uterus from the abdominal cavity. MAIN OUTCOME MEASURES: Patient satisfaction, morbidity rates and readmission rates.
RESULTS: A total of 400 LSH were performed between February 2003 and November 2006. The principal clinical indication for hysterectomy was menorrhagia. The mean duration of surgery was 46.4 minutes. The mean operative blood loss was 126 ml. Concurrent surgery was performed in 141 women. Minor and major perioperative complications were encountered in 5% (n= 20) of women. The major complication rate was 1.2% (n= 5): three women (0.75%) with bladder perforation, two women (0.5%) with bowel injury and one woman (0.25%) with a vesicocervical fistula. Eight women (2%) suffered from cyclical vaginal bleeding postoperatively.
CONCLUSIONS: LSH is a safe and effective treatment for menorrhagia and other menstrual disorders when hysterectomy is indicated. Women appreciate the quick recovery period, reduced time off work and faster return to normal activity. Our data suggest that LSH can replace abdominal hysterectomy in selected cases.

Entities:  

Mesh:

Year:  2008        PMID: 18410659     DOI: 10.1111/j.1471-0528.2008.01698.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

Review 1.  Gynecare Morcellex Sigma(®): Manufacturer: ETHICON Women's Health & Urology, A Division of ETHICON, INC., a Johnson & Johnson company, Somerville, NJ 08876-0151, USA, © ETHICON, INC. 2005.

Authors:  Avishalom Sharon
Journal:  J Obstet Gynaecol India       Date:  2014-06

2.  Cervical Detachment Using Monopolar SupraLoop™ Electrode versus Monopolar Needle in Laparoscopic Supracervical Hysterectomy (LSH): An Interventional, Comparative Cohort Study.

Authors:  S Brucker; R Rothmund; B Krämer; F Neis; B Schönfisch; W Zubke; F A Taran; M Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-11       Impact factor: 2.915

3.  Long-term follow-up of the outcome of supracervical versus total abdominal hysterectomy.

Authors:  Seija Ala-Nissilä; Mervi Haarala; Tuija Järvenpää; Juha Mäkinen
Journal:  Int Urogynecol J       Date:  2016-09-17       Impact factor: 2.894

Review 4.  Specimen processing during laparoscopic renal surgery: a review of techniques and technologies.

Authors:  Saleh Binsaleh
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

5.  Unexpected Leiomyosarcoma 4 Years after Laparoscopic Removal of the Uterus Using Morcellation.

Authors:  J R Prins; M W Van Oven; J M Helder-Woolderink
Journal:  Case Rep Obstet Gynecol       Date:  2015-09-29

6.  The Changes of Surgical Treatment for Symptomatic Uterine Myomas in the Past 15 Years.

Authors:  Weihong Yang; Ning Luo; Lishan Ma; Hong Dai; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2018-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.